Navigation Links
BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
Date:6/25/2008

NEWARK, N.J., June 25 /PRNewswire/ -- BioNeutral announced today that Steve Browand will direct the company's efforts to sell its advanced chemical technology products to the military, Homeland Security and governmental departments. Steve Browand said, "I have reviewed the test results announced by Dr. Tierno, regarding anthrax, the attached video interview with Dr. Kielbania and Dr Tierno and the performance of the company's formulations in combating chemical and biologic threats and I believe it to be world-class. I will be meeting with military and government officials who have conveyed their interest in this powerful next-generation defensive tool."

YouTube link: http://www.youtube.com/watch?v=FOlnXLp1Itg

"Mr. Browand's extensive security and diverse business experience spans over 30 years from multiple sectors, including military, municipal and private. He started his career as an intelligence officer serving in the European theatre, where he gained experience in the areas of vulnerability analysis, counter-terrorism, strike contingency planning, emergency management and the deployment of counter-intelligence safeguards. This experience has enabled Mr. Browand to add considerable value to our company," said Raj Pamani, Director of BioNeutral.

About BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.

BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest-acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.

About Dr. Philip Tierno

Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. He is also an Associate Professor at the New York University School of Medicine, NYU College of Dentistry and SUNY School of Optometry in New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve Corps) and a former member of New York City's task force on bioterrorism. Dr. Tierno's work in the field of microbiology has resulted in numerous articles and texts that have been published in medical and scientific journals. He is co-editor and author of several books on microbes and biological protection.

Contact:

Info@bioneutralgroup.com

Stephen J. Browand

Director

Governmental Affairs

steve@bioneutralgroup.com

Dr. Philip Tierno

Consultant

philip.tierno@nyumc.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioNeutral Laboratories Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
2. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
3. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)
4. Barrier Therapeutics to Merge Into Stiefel Laboratories
5. ARUP Laboratories Partners With Pathology Service Associates
6. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
7. Cato Research and Neuland Laboratories Form Cato Research Neuland India, Ltd.
8. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
9. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
10. IDEXX Laboratories Announces First Quarter Results
11. ARUP Laboratories CEO and Co-Founder Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... USARAD ... company announces at HIMSS 2017 Annual Conference (Orlando, FL) a world-wide distribution ... a global cloud-based sharing and collaboration platform as part of the Siemens ...
(Date:2/20/2017)... ORLANDO, Fla. , Feb. 20, 2017 /PRNewswire/ ... (HIMSS) conference in Orlando , ... new offerings, collaborators and clients. IBM Chairman, President ... the HIMSS17 opening keynote address today from 8:30-10 ... www.ibm.com/watson/health , and ibm.com/industries/healthcare. Her remarks examine ...
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant ... Center in Orlando, Fla. , The combined scientific sessions offer investigators, ...
(Date:2/17/2017)... Feb. 17, 2017  BioGenex, a global leader ... of a novel system for quantitative immunohistochemistry (IHC). ... University of Rochester (NY, USA) and Konica-Minolta Inc. ... system is able to accurately quantify the expression ... epidermal growth factor receptor-2) in clinical samples. Quantitative ...
Breaking Biology Technology:
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
(Date:1/21/2017)... 20, 2017 Research and Markets has announced ... report to their offering. ... The global voice recognition biometrics market to grow ... The report covers the present scenario and the growth prospects ... the market size, the report considers the revenue generated from the ...
Breaking Biology News(10 mins):